Drug Database
Back to search

France· FR:67410412

THERALENE 4 POUR CENT, solution buvable

A alimemazine product containing tartrate d'alimémazine, registered in France by LABORATOIRE XO, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC R06AD01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTHERALENE 4 POUR CENT, solution buvab…ATCR06AD01REGISTER NO.FR:67410412PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tartrate d'alimémazineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Alimemazine is registered in 9 of 19 countries.

Countries holding a registration under ATC R06AD01 (alimemazine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search alimemazine products by name

Alimemazine · ATC R06AD01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Japan
  • Norwayprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alimemazine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • France: $0.25 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Alimemazine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TARTRATE D'ALIMÉMAZINE
Manufacturer
LABORATOIRE XO
Country
France (FR)
ATC code
R06AD01
ATC class
Alimemazine
Defined daily dose
30 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400931053088
    1 flacon(s) en verre brun de 30 ml avec pipette doseuse polyéthylène polystyrène
    EUR 1.99
  • cip13
    3400955474012
    1 flacon(s) en verre brun de 100 ml avec pipette doseuse polyéthylène polystyrène

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

659 interactions on record for alimemazine.

Graded by severity as the source publishes them — 80 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check alimemazine against other medicinesHow interaction checks work

Alimemazine · interactions on record

659 records

  • 80 severe
  • 565 moderate
  • 14 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alimemazine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alimemazine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Spain · Variargil
  • United Kingdom (Northern Ireland) · Alfresed, Alimemazine Tartrate
  • Iceland · Alimemazin Evolan
  • Malta · Alimemazine Thame
  • Norway · Alimemazin Evolan, Alimemazin Orifarm
  • Sweden · Alimemazin Evolan, Alimemazin Orifarm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/86b782b9-7237-484d-936d-4eb54cfcdf3b
GET /v1/drugs/86b782b9-7237-484d-936d-4eb54cfcdf3b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67410412",
  "date_amm": "1997-12-17",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "TARTRATE D'ALIMÉMAZINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about alimemazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console